<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39316309</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2869</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of urban health : bulletin of the New York Academy of Medicine</Title><ISOAbbreviation>J Urban Health</ISOAbbreviation></Journal><ArticleTitle>Scale-Up of COVID-19 Testing Services in NYC, 2020-2021: Lessons Learned to Maximize Reach, Equity and Timeliness.</ArticleTitle><Pagination><StartPage>913</StartPage><EndPage>922</EndPage><MedlinePgn>913-922</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11524-024-00918-z</ELocationID><Abstract><AbstractText>During infectious disease epidemics, accurate diagnostic testing is key to rapidly identify and treat cases, and mitigate transmission. When a novel pathogen is involved, building testing capacity and scaling testing services at the local level can present major challenges to healthcare systems, public health agencies, and laboratories. This mixed methods study examined lessons learned from the scale-up of SARS-CoV-2 testing services in New York City (NYC), as a core part of NYC's Test &amp; Trace program. Using quantitative and geospatial analyses, the authors assessed program success at maximizing reach, equity, and timeliness of SARS-CoV-2 diagnostic testing services across NYC neighborhoods. Qualitative analysis of key informant interviews elucidated key decisions, facilitators, and barriers involved in the scale-up of SARS-CoV-2 testing services. A major early facilitator was the ability to establish working relationships with private sector vendors and contractors to rapidly procure and manufacture necessary supplies locally. NYC residents were, on average, less than 25 min away from free SARS-CoV-2 diagnostic testing services by public transport, and services were successfully directed to most neighborhoods with the highest transmission rates, with only one notable exception. A key feature was to direct mobile testing vans and rapid antigen testing services to areas based on real-time neighborhood transmission data. Municipal leaders should prioritize fortifying supply chains, establish cross-sectoral partnerships to support and extend testing services, plan for continuous testing and validation of assays, ensure open communication feedback loops with CBO partners, and maintain infrastructure to support mobile services during infectious disease emergencies.</AbstractText><CopyrightInformation>© 2024. The New York Academy of Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thorpe</LastName><ForeName>Lorna E</ForeName><Initials>LE</Initials><Identifier Source="ORCID">0000-0001-7515-0562</Identifier><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA. lorna.thorpe@nyulangone.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conderino</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendik</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massar</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chau</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Margaret M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Division of Health Care Delivery, Mayo Clinic, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Chuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fair</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Titus</LastName><ForeName>Andrea R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bershteyn</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallach</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Office of Ambulatory Care, New York City Health + Hospitals, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Urban Health</MedlineTA><NlmUniqueID>9809909</NlmUniqueID><ISSNLinking>1099-3460</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009519" MajorTopicYN="N" Type="Geographic">New York City</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="Y">COVID-19 Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Equity</Keyword><Keyword MajorTopicYN="N">New York City</Keyword><Keyword MajorTopicYN="N">Reach</Keyword><Keyword MajorTopicYN="N">Testing services</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39316309</ArticleId><ArticleId IdType="pmc">PMC11461424</ArticleId><ArticleId IdType="doi">10.1007/s11524-024-00918-z</ArticleId><ArticleId IdType="pii">10.1007/s11524-024-00918-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sridhar S, To KK, Chan JF, Lau SK, Woo PC, Yuen KY. A systematic approach to novel virus discovery in emerging infectious disease outbreaks. J Mol Diagn. 2015;17(3):230–41. 10.1016/j.jmoldx.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7106266</ArticleId><ArticleId IdType="pubmed">25746799</ArticleId></ArticleIdList></Reference><Reference><Citation>Tognotti E. Lessons from the history of quarantine, from plague to influenza A. Emerg Infect Dis. 2013;19(2):254–9. 10.3201/eid1902.120312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3559034</ArticleId><ArticleId IdType="pubmed">23343512</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack A, Choffnes ER, Sparling PF, Hamburg MA, Lemon SM. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington (DC). National Academies Press; 2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">21595110</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JF, Sridhar S, Yip CC, Lau SK, Woo PC. The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic. J Microbiol. 2017;55(3):172–182. 10.1007/s12275-017-7026-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7090747</ArticleId><ArticleId IdType="pubmed">28243939</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JY, You Z, Wang Q, et al. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect. 2020;22(2):80–85. 10.1016/j.micinf.2020.02.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079563</ArticleId><ArticleId IdType="pubmed">32087334</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration. COVID-19 Emergency Use Authorizations for Medical Devices. https://www.fda.gov/medical-devices/emergency-use-authorizations-medical-devices/covid-19-emergency-use-authorizations-medical-devices. Accessed 19 Apr 2021.</Citation></Reference><Reference><Citation>Conderino S, Thorpe L, Islam N, Berry C, Bendik S, Massar R, Hong C, Fair A, Bershteyn A. (in press). Evaluation of the New York City COVID-19 case investigation and contact tracing program: a cascade of care analysis. BMC Public Health. 2024;24(1):1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11363647</ArticleId><ArticleId IdType="pubmed">39210385</ArticleId></ArticleIdList></Reference><Reference><Citation>New York City Department of Health and Mental Hygiene. coronavirus-data/trends/. https://github.com/nychealth/coronavirus-data/tree/master/trends. Accessed 29 Aug 2022.</Citation></Reference><Reference><Citation>The Internet Archive. Wayback Machine. https://archive.org/web/. Accessed 1 Jun 2022.</Citation></Reference><Reference><Citation>Bureau UC. TIGER/Line shapefiles. US Census Bureau. https://www2.census.gov/geo/tiger/TIGER2020/ZCTA520/. Accessed 1 Jun 2022.</Citation></Reference><Reference><Citation>City of New York. NYC OpenData. Secondary NYC OpenData. https://opendata.cityofnewyork.us/. Accessed 1 Jun 2022.</Citation></Reference><Reference><Citation>Rubin R. The challenges of expanding rapid tests to curb COVID-19. JAMA. 2020;324(18):1813–1815. 10.1001/jama.2020.21106.</Citation><ArticleIdList><ArticleId IdType="pubmed">33084882</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong S. Covid-19: tests on students are highly inaccurate, early findings show. BMJ. 2020;371:m4941. 10.1136/bmj.m4941.</Citation><ArticleIdList><ArticleId IdType="pubmed">33361271</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration. Statistical guidance on reporting results from studies evaluating diagnostic tests. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-guidance-reporting-results-studies-evaluating-diagnostic-tests-guidance-industry-and-fda. Accessed 1 Jun 2022</Citation></Reference><Reference><Citation>Tu YP, Jennings R, Hart B, et al. Swabs collected by patients or health care workers for SARS-CoV-2 testing. N Engl J Med. 2020;383(5):494–496. 10.1056/NEJMc2016321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289274</ArticleId><ArticleId IdType="pubmed">32492294</ArticleId></ArticleIdList></Reference><Reference><Citation>NYC Health + Hospitals. COVID-19 Rapid Test Pickup Sites. https://www.nychealthandhospitals.org/covid-19-rapid-test-pickup-sites/. Accessed  12 Feb 2024.</Citation></Reference><Reference><Citation>Data Commons. Place Explorer. https://datacommons.org/place/geoId/36005. Updated June 30, 2022. Accessed 1 Aug 2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>